Home/Filings/4/0000914190-13-000681
4//SEC Filing

Cardiovascular Systems Inc 4

Accession 0000914190-13-000681

CIK 0001180145operating

Filed

Sep 22, 8:00 PM ET

Accepted

Sep 23, 4:07 PM ET

Size

12.8 KB

Accession

0000914190-13-000681

Insider Transaction Report

Form 4
Period: 2013-09-19
Flaherty James E
Chief Administrative Officer
Transactions
  • Sale

    Common Stock

    2013-09-19$20.32/sh1,882$38,242140,920 total
  • Sale

    Common Stock

    2013-09-20$19.82/sh184$3,647140,736 total
Holdings
  • Stock Option (right to buy)

    Exercise: $7.90Exp: 2017-08-06Common Stock (19,388 underlying)
    19,388
  • Stock Option (right to buy)

    Exercise: $12.15Exp: 2017-12-11Common Stock (24,120 underlying)
    24,120
  • Stock Option (right to buy)

    Exercise: $8.75Exp: 2019-03-02Common Stock (10,999 underlying)
    10,999
  • Stock Option (right to buy)

    Exercise: $8.83Exp: 2017-04-17Common Stock (8,624 underlying)
    8,624
Footnotes (4)
  • [F1]In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.10 to $20.79 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.80 to $20.02 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]Fully exercisable.

Issuer

Cardiovascular Systems Inc

CIK 0001180145

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001180145

Filing Metadata

Form type
4
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 4:07 PM ET
Size
12.8 KB